Search Results

Displaying: 25 / 100 / 200 results

Ordered by: Date (newest first) / Date (oldest first)

Platform to expand in agrochemicals by buying Arysta

29 October 2014 Business

Business will be integrated with previous acquisitions for a broad crop protection portfolio

EU warns DuPont and Honeywell over green refrigerants

29 October 2014 Business

Commission thinks cooperation may have been anti-competitive

Judge slashes fines in drug safety case

29 October 2014 Business

Takeda and Eli Lilly’s $9 billion damages in diabetes trial reduced to $38 million

CHF3bn redevelopment for Roche’s Basel site

29 October 2014 Business

New buildings will move employees out of rented office space

Amgen stacks up additional job cuts

28 October 2014 Business

Up to 1100 more staff face redundancy in ongoing restructuring plan

Ineos bets big on shale

27 October 2014 Business

UK profit-sharing plan and transatlantic ethane shipping contracts show company’s commitment to a fracking future

Amgen seeks injunction to protect patents

23 October 2014 Business

Sanofi and Regeneron sued over cholesterol-regulating antibodies

Agilent to exit NMR

23 October 2014 Business

Closure of loss-making ex-Varian business gives users investment dilemma

EPA takes steps to prevent herbicide resistance in weeds

22 October 2014 Business

US Agency approves spray for resistant engineered crops, but with restrictions and time limit

AbbVie backs out of Shire deal

17 October 2014 Business

Treasury rule changes make inversion ‘too uncertain’ and remove financial benefits

Indian manufacturers hit back over quality claims

17 October 2014 Business

Study showing drugs exported to Africa are substandard prompts backlash from generic drugmakers

Bio-based chemicals on the rise in US

16 October 2014 Business

Government predicts 10% of chemicals market will be renewable by 2015

Endo outbids QLT for Auxilium merger

10 October 2014 Business

Biotech backs out of Canadian deal in favour of increased $2.6bn bid from Endo

EMA finalises trial transparency rules

8 October 2014 Business

Researcher access reinstated, but company redaction rights may cause issues

Actavis boosts antibiotics with Durata buyout

8 October 2014 Business

$820 million deal gives Actavis control of newly-approved intravenous antibiotic

US tax changes ripple into merger deals

8 October 2014 Business

Efforts to curb tax-avoiding ‘inversion’ deals will slow, but not stop, the wave

Becton Dickinson to buy CareFusion for $12bn

7 October 2014 Business

Medical devices merger continues consolidation trend

J&J to buy antiviral specialist Alios

1 October 2014 Business

$1.75 billion deal brings Phase II compounds for hepatitis C and respiratory syncytial virus

Dow’s $1bn price-fixing fine upheld

1 October 2014 Business

Firm loses its appeal against damages for fixing polyurethane prices

Lumara splits and sells to AMAG and Perrigo

30 September 2014 Business

Lumara has just emerged from bankruptcy and brings a drug for suppressing pre-term birth, plus other women’s health products

Mitsubishi to buy Japanese gases specialist

30 September 2014 Business

Taiyo Nippon Sanso acquisition continues consolidation in Japan’s chemical industry

Merck KGaA to buy Sigma–Aldrich

26 September 2014 Business

$17bn acquisition expands Merck’s life science business and US presence, but it isn’t stepping back from drug development

India backs off drug pricing controls

25 September 2014 Business

Current price caps will stand, but rules on how new caps can be imposed are being tightened

GSK fined £300 million for China corruption

25 September 2014 Business

Several top executives jailed or deported

Review says cheaper drug is safe for eye disease

24 September 2014 Business

Cochrane collaboration says side effects of expensive Lucentis and off-label Avastin are similar